首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 生物科技之投資與商業趨勢
產業/市場分類
生物科技 (1470)
分子標靶治療學 (51)
生技設備 (321)
生物材料 (55)
生物標記 (157)
以基因為基之藥物開發 (201)
再生醫學 (120)
抗體和免疫 (187)
個人化醫學 (54)
基因治療學和RNAi (101)
市場調查報告書

生物科技之投資與商業趨勢

Who's Buying What in Biotech? Investment and Business Trends Driving Biotechnology

出版商 Decision Resources, Inc.
出版日期 2006年04月 商品編碼 38526
內容資訊 英文 Pages: 24
價格
本報告書已不再販售

本報告已在2011年12月21日停止出版。

簡介

2005 年是生物科技產業初次發行股票起 25 周年。投資企業相信生物科技相關股價會上昇,並抱持樂觀的態度。

專門於醫療產業廣泛調查工作的美國調查公司 Decision Resources Inc. (總公司:麻薩諸塞州),針對生物科技的投資與商業趨勢進行調查分析,經系統整理後出版報告書 "Who's Buying What in Biotech? Investment and Business Trends Driving Biotechnology" 。

本報告書內容包括: 2005 年生物科技產業趨勢、對該產業的財務支援、進入市場企業之趨勢與技術簡介、今後預測等。共計 24 頁的內容綱要摘記如下:

概述

生物科技相關交易趨勢

  • 主要發展
  • 主要生物辦識
  • 主要最適化

企業購併

對生物科技的財政支援趨勢

  • 新發行股票上市
  • 創投資金方式融資
    • A 系列財政
    • 產品企業 對 平台企業
  • 計畫融資

生物科技產業的商業趨勢與技術趨勢

  • 生物標記、展開醫療、藥物基因體
  • 藥劑定位之變更及併用治療
  • 幹細胞
  • 資訊科學

展望

目錄

Abstract

In This Issue.

2005 marked the 25th anniversary of the first biotechnology IPO. In the ensuing years, investment firms that have a sophisticated understanding of both the complex science and business of biotechnology remain bullish on the industry because of its ability to dramatically outperform the S&P 500 during biotech stock market surges. The major challenge for the biotechnology industry now is to find solutions for the current gap in financing for early-stage companies--a shortfall that threatens to disrupt the flow of new innovations into the biotechnology and pharmaceutical industries. We argue that it is imperative for the health of the pharmaceutical industry to continue to support a large, fragmented pool of biotechnology companies to ensure the creation of a variety of new approaches to drug discovery and therapy. In this report, we review trends in biotechnology in 2005, particularly in the context of biotechnology dealmaking. This perspective is important because deal-making activity reflects the current thinking and direction of both the business and science of drug discovery.

Table of Contents

Overview

Trends in Biotechnology Dealmaking

  • Lead Development
  • Lead Identification
  • Lead Optimization
  • Target Identification and Validation

Mergers and Acquisitions

Trends in Biotechnology Financing

  • Initial Public Offerings
  • Venture Capital Financings
    • Series A Financings
    • Product vs. Platform Companies
  • Project Financing

Trends in the Business and Technology of Biotech

  • Biomarkers, Translational Medicine, and Pharmacogenomics
  • Drug Repositioning and Combination Therapies
  • Stem Cells
  • Informatics

Outlook

Back to Top